Suppr超能文献

心房利钠肽用于监测起搏器植入后的心血管系统功能

Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation.

作者信息

Sielski Janusz, Janion Marianna, Gawor Zenon

机构信息

Department of Cardiology, District Hospital, ul. Grunwaldzka 45, 25-736 Kielce, Poland.

出版信息

Kardiol Pol. 2005 Mar;62(3):202-9; discussion 210.

Abstract

BACKGROUND

The effects of different modes of pacing on cardiac performance have been investigated in a few small studies, and the results are not conclusive.

AIM

To assess the effects of different modes of pacing on atrial natriuretic peptide (ANP) plasma concentration and left ventricular ejection fraction (LVEF).

METHODS

The study group consisted of 55 subjects without symptomatic CHF. Forty patients were in sinus rhythm and had a-v block. Twenty of them, aged 71-90 years, mean 77.5+/-5.9 years, received VVI pacemaker, and the remaining 20 patients aged 49-81 years, mean 68.9+/-11.9 years, received DDD or VDD pacemakers. The control group consisted of 15 healthy volunteers aged 58-80 years, mean 72.6+/-2.8 years. Blood samples for alpha ANP concentration were taken before pacemaker implantation and 7 as well as 30 days after pacemaker implantation. In controls, a single alpha ANP measurement was performed. Transthoracic echocardiography was performed in all patients and controls at the same time-points as ANP assessment in order to calculate LVEF.

RESULTS

Before pacemaker implantation, ANP plasma concentration was the highest in VVI patients and was significantly greater in patients than in controls. Following VVI pacemaker implantation, ANP level significantly decreased, both 7 and 30 days after implantation when compared with baseline values. Also following implantation of dual-chamber pacing system, ANP concentration significantly decreased. The baseline LVEF values were significantly higher in patients than in controls. In patients with VVI pacemakers, LVEF significantly increased, both 7 and 30 days after implantation. In patients with dual-chamber pacemakers, LVEF tended to increase 7 days after implantation and slightly decreased 30 days after implantation, however, the differences were not significant.

CONCLUSIONS

ANP level decreases following pacemaker implantation in patients with advanced a-v block which suggests an improvement of cardiac performance. Assessment of ANP may be useful in selection of pacing mode.

摘要

背景

少数小型研究对不同起搏模式对心脏功能的影响进行了调查,结果尚无定论。

目的

评估不同起搏模式对心房利钠肽(ANP)血浆浓度和左心室射血分数(LVEF)的影响。

方法

研究组由55例无症状心力衰竭患者组成。40例患者为窦性心律且存在房室传导阻滞。其中20例年龄在71 - 90岁,平均年龄77.5±5.9岁,接受VVI起搏器治疗;其余20例年龄在49 - 81岁,平均年龄68.9±11.9岁,接受DDD或VDD起搏器治疗。对照组由15名年龄在58 - 80岁,平均年龄72.6±2.8岁的健康志愿者组成。在起搏器植入前、植入后7天以及30天采集血样检测α - ANP浓度。对照组进行单次α - ANP测量。在与ANP评估相同的时间点,对所有患者和对照组进行经胸超声心动图检查以计算LVEF。

结果

在起搏器植入前,VVI患者的ANP血浆浓度最高,且患者的浓度显著高于对照组。植入VVI起搏器后,与基线值相比,植入后7天和30天ANP水平均显著降低。双腔起搏系统植入后,ANP浓度也显著降低。患者的基线LVEF值显著高于对照组。在植入VVI起搏器的患者中,植入后7天和30天LVEF均显著增加。在植入双腔起搏器的患者中,植入后7天LVEF有增加趋势,植入后30天略有下降,但差异无统计学意义。

结论

晚期房室传导阻滞患者植入起搏器后ANP水平降低,提示心脏功能改善。ANP评估可能有助于起搏模式的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验